Literature DB >> 18707864

Microsatellite instability in sporadic colon carcinomas has no independent prognostic value in a Belgian study population.

Vanessa Deschoolmeester1, Nancy Van Damme, Marc Baay, Kathleen Claes, Eric Van Marck, Filip J Baert, Wim Wuyts, Marc Cabooter, Joost Weyler, Peter Vermeulen, Filip Lardon, Jan B Vermorken, Marc Peeters.   

Abstract

Pathological stage is currently the most important determinant of colorectal cancer prognosis. Hence, identification of additional prognostic markers is warranted. This study aimed to analyse the prognostic relevance of microsatellite instability (MSI) in 241 colon and 90 rectal tumours, using a mononucleotide loci multiplex PCR assay and immunohistochemistry. Thirty (12.4%) colon tumours and one rectal tumour showed MSI. Although MSI was associated with proximal location and poor differentiation, no survival benefit was observed. The prognostic value of stage and differentiation was confirmed in this study. Analysis by stage revealed a longer overall (stage II/III) and disease free survival (stage II) for patients with well differentiated tumours. In addition, age and distal localisation were related to longer overall survival in stage II tumours. In conclusion, our findings show an association of MSI in sporadic colon tumours and certain clinical features; however, they do not suggest a survival benefit for MSI tumours.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18707864     DOI: 10.1016/j.ejca.2008.06.043

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  11 in total

1.  Clinicopathologic features and prognostic analysis of MSI-high colon cancer.

Authors:  Chun-Chi Lin; Yi-Ling Lai; Tzu-Chen Lin; Wei-Shone Chen; Jeng-Kai Jiang; Shung-Haur Yang; Huann-Sheng Wang; Yuan-Tzu Lan; Wen-Yih Liang; Hui-Mei Hsu; Jen-Kou Lin; Shih-Ching Chang
Journal:  Int J Colorectal Dis       Date:  2011-11-12       Impact factor: 2.571

Review 2.  A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy.

Authors:  Vanessa Deschoolmeester; Marc Baay; Pol Specenier; Filip Lardon; Jan B Vermorken
Journal:  Oncologist       Date:  2010-06-28

Review 3.  The Worse Prognosis of Right-Sided Compared with Left-Sided Colon Cancers: a Systematic Review and Meta-analysis.

Authors:  Masashi Yahagi; Koji Okabayashi; Hirotoshi Hasegawa; Masashi Tsuruta; Yuko Kitagawa
Journal:  J Gastrointest Surg       Date:  2015-11-16       Impact factor: 3.452

4.  Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.

Authors:  Vanessa Deschoolmeester; Marc Baay; Eric Van Marck; Joost Weyler; Peter Vermeulen; Filip Lardon; Jan B Vermorken
Journal:  BMC Immunol       Date:  2010-04-12       Impact factor: 3.615

5.  Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer.

Authors:  Vanessa Deschoolmeester; Veerle Van Marck; Marc Baay; Christine Weyn; Peter Vermeulen; Eric Van Marck; Filip Lardon; Veronique Fontaine; Jan B Vermorken
Journal:  BMC Cancer       Date:  2010-03-26       Impact factor: 4.430

6.  KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis.

Authors:  V Deschoolmeester; C Boeckx; M Baay; J Weyler; W Wuyts; E Van Marck; M Peeters; F Lardon; J B Vermorken
Journal:  Br J Cancer       Date:  2010-10-19       Impact factor: 7.640

7.  Microsatellite instability and B-type Raf proto-oncogene mutation in colorectal cancer: Clinicopathological characteristics and effects on survival.

Authors:  Sebnem Batur; Dogu Vuralli Bakkaloglu; Nuray Kepil; Sibel Erdamar
Journal:  Bosn J Basic Med Sci       Date:  2016-11-10       Impact factor: 3.363

8.  Human mutL homolog 1 expression characteristic and prognostic effect on patients with sporadic colorectal cancer.

Authors:  Chibin Pu; Weiguo Ren; Zhenqiang Sun; Xianbo Yu; Wei Yuan; Mingyu Huang; Shourong Shen; Xiaoyan Wang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 9.  Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.

Authors:  Sabine Tejpar; Monica Bertagnolli; Fred Bosman; Heinz-Joseph Lenz; Levi Garraway; Frederic Waldman; Robert Warren; Andrea Bild; Denise Collins-Brennan; Hejin Hahn; D Paul Harkin; Richard Kennedy; Mohammad Ilyas; Hans Morreau; Vitali Proutski; Charles Swanton; Ian Tomlinson; Mauro Delorenzi; Roberto Fiocca; Eric Van Cutsem; Arnaud Roth
Journal:  Oncologist       Date:  2010-03-29

10.  Current status on microsatellite instability, prognosis and adjuvant therapy in colon cancer: A nationwide survey of medical oncologists, colorectal surgeons and gastrointestinal pathologists.

Authors:  James W T Toh; Hema Mahajan; Pierre Chapuis; Kevin Spring
Journal:  Cancer Rep (Hoboken)       Date:  2020-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.